Top 50 Generic Drug Manufacturers Globally Examined by Visiongain

15 May 2012 • by Natalie Aster

How are companies in the generics market performing? The new report “Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022” by Visiongain provides data, analyses and discussions for the world’s leading manufacturers of generic drugs.

Report Details:

Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022
Published: March, 2012
Pages: 223
Price: US$ 2.642,00

The investigation gives business research and analysis, including revenue forecasts to 2022. Commercial data, predictions and discussions for companies and the market in which they operate are also available.

Many opportunities exist, especially in Japan and developing countries. Generic substitution is rising in Europe and the US.

As this study shows, there are many companies breaking into new markets and expanding generic product ranges.

Complex generics, with high market entry barriers, and biosimilar (follow-on biologic/protein) products will transform the generics industry and pharma markets. Many opportunities exist for drug companies with biotechnological capabilities. The report shows and explains.

The patent cliff will result in many more of the pharmaceutical industry's blockbusters being opened to generic competition.

There are historical revenues, sales predictions, growth rates and market breakdowns in the report. Also, discussions of companies, product portfolios and growth potential are provided.

In particular, the study gives the following knowledge on the topic:

  • Assess 50 leading generics producers, discovering their activities and outlooks 
  • Discover market leaders in each region 
  • Receive analyses of leading companies, seeing revenue forecasts to 2022 
  • View a comparative analysis of generics players 
  • Assess commercial prospects, market breakdowns and product offerings 
  • Find existing revenues and operational data for leading companies 
  • Review technological, regulatory and commercial developments, assessing trends and prospects 
  • Analyse prospects for generic drug launches 
  • Investigate competition and opportunities influencing revenues 
  • Find out what will stimulate and restrain the industry and market.
  • The study is for everybody needing industry and market analyses for generic drug companies.

More information can be found in the report “Pharma Leader Series: Top 50 Generic Drug Manufacturers 2012-2022” by Visiongain.

To order the report or ask for sample pages contact


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970